226 Bipartisan U.S. House Members Ask HHS to Stop Pharma From Unilaterally Changing 340B

Slightly more than half of all U.S. Representatives signed the Feb. 26 letter to HHS urging immediate action to stop drug manufacturers from making unilateral changes to 340B | Shutterstock

Two hundred and twenty six U.S. House members—173 Democrats and 57 Republicans—have signed a letter to U.S. Health and Human Services (HHS) Acting Secretary Norris Cochran asking him “to take immediate action to ensure that manufacturers are prohibited from imposing

Read More »

Express Scripts’ New 340B Rules Will Have Big Impact on Contract Pharmacy and Drug Reimbursement, Providers and Consultants Say

340B covered entities fault Express Scripts for not communicating with them more effectively about changes in its 340B claims identification and reporting requirements, which the entities consider to be major.

340B covered entities say they are deeply concerned about pharmacy benefit manager Express Scripts’ (ESI) requirements, effective Monday, governing what pharmacies in the PBM’s network must do when they identify that a previously submitted claim is 340B-eligible. Last night, ESI told

Read More »

Bipartisan U.S. House Members Corralling Last-Minute Signatures on 340B Letter to HHS

Rep. Abigail D. Spanberger (D-Va.) is one of six U.S. House members urging colleagues to sign a bipartisan letter to HHS leadership on 340B. | C-SPAN

Today is the deadline for U.S. House members to sign a bipartisan letter asking U.S. Health and Human Services Department (HHS) leaders to act against drug manufacturers denying 340B pricing on drugs, to halt attempts to turn 340B into a

Read More »

Becerra Reconfirms Strong Support for 340B During Finance Committee Hearing

HHS Secretary-designate Xavier Becerra said he "absolutely" would commit himself to ensuring the 340B program's strength, in response to a question from Sen. John Thune (R-S.D.) | C-SPAN

Xavier Becerra, President Biden’s pick to be the next U.S. Health and Human Services (HHS) Secretary survived his U.S. Senate Finance Committee confirmation hearing yesterday, with a GOP foe of his nomination grudgingly predicting the panel would vote to confirm

Read More »

Express Scripts’ New 340B Claims ID Requirement Has Covered Entities Worried

The 340B Coalition told Express Scripts that covered entities cannot comply with its new 340B claims submission and identification requirement absent "a massive investment of financial and human resources." | Shutterstock

Pharmacy benefit manager Express Scripts late yesterday began notifying 340B covered entities by email that, effective March 1, it “will require a new identification method for submitting and identifying 340B eligible claims.”

A health system 340B program manager said this

Read More »

Hospitals, Health Centers, and HIV/AIDS Clinics Want Roles in Lilly’s 340B Contract Pharmacy Lawsuit

Hospital, health center, and HIV/AIDS clinic association have asked a federal district court in Indiana to let them have a role in drug manufacturer Eli Lilly's 340B contract pharmacy lawsuit against the federal government.

The hospital groups that last week lost a federal lawsuit in California to make federal health officials enforce 340B contract pharmacy requirements for drug manufacturers have asked a federal court in Indiana to make them parties in opposition to manufacturer

Read More »

Health Care Reporter Foresees Federal Action on Drug Pricing, But Not Immediately

Politico Pro reporter Sarah Owermohle told 340B Coalition winter conference attendees she thinks President Biden will turn to drug pricing after dealing first with the COVID-19 pandemic and bolstering the Affordable Care Act.

The U.S. Senate Finance Committee’s new Democratic chair is considering bringing back a bipartisan bill from the last session of Congress that would require drug manufacturers to pay the federal government rebates on Medicare Part B and Part D drugs

Read More »

36 State Hospital Groups Ask U.S. Supreme Court to End Part B Drug Payment Cuts for 340B Hospitals

If a federal appeals court's decision stands, a nearly 30 percent cut since 2018 in 340B hospitals’ Medicare Part B drug reimbursement "will devastate 340B hospitals and the communities they serve," 36 hospitals groups told the U.S.Supreme Court.

Thirty-six state and regional hospital associations on Tuesday urged the U.S. Supreme Court to overturn a federal appeals court’s 2-1 July 2020 decision that upheld the nearly 30 percent cut since 2018 in 340B hospitals’ drug reimbursement under the hospital

Read More »

BREAKING: HHS Secretary-Designate Becerra Pledges to “Build On” 340B Contract Pharmacy Advisory Opinion

HHS Secretary-designate Xavier Becerra called 340B "an indispensable program" during a courtesy hearing before the Senate HELP Committee today.

President Biden’s pick to serve as U.S. Health and Human Services (HHS) secretary expressed his support for the recent HHS advisory opinion on contract pharmacy during questions today before a key congressional committee.

California Attorney General Xavier

Read More »

HHS-Designate Becerra May Face 340B Questions Today During First Nomination Hearing

HHS-Secretary designate Xavier Becerra could face questions about the 340B program today during his first of two Senate nomination hearings this week.

The U.S. Senate Health, Education, Labor, and Pensions (HELP) Committee this morning is holding the first of two Senate committee hearings this week on President Biden’s nomination of California Attorney General Xavier Becerra to serve as U.S. Health and Human

Read More »